Healthcare

A notable upgrade from analysis platform Wall Street Zen has introduced a contrasting perspective on Organon & Co., setting it...

Redcare Pharmacy is entering 2026 under significant strain. The MDAX-listed company's shares have lost approximately half their value over the...

The telehealth provider Hims & Hers officially launched operations in Canada on December 4, 2025. This strategic move was executed...

As the year draws to a close, UnitedHealth Group faces a confluence of high-stakes operational and regulatory challenges. The outcomes...

The German biotech firm BioNTech is decisively pivoting beyond its pandemic-era identity, placing a substantial strategic bet on mRNA oncology....

The story of Healwell AI's stock is one of stark contrasts. While the company's latest financial reports reveal explosive revenue...

Shares of Viking Therapeutics gained approximately 2.9% to $36.42 following a pivotal regulatory decision that is reshaping the market for...

The investment case for Hims & Hers Health is currently defined by a stark tug-of-war. On one side, a bold...

Semler Scientific stands at a strategic crossroads, poised for a fundamental transformation. The medical diagnostics firm is charting a course...

Shares of medical device leader Abbott Laboratories opened the week on stable footing following a significant regulatory achievement. The company...